Literature DB >> 12949812

Simultaneous onset of acute inflammatory response, sepsis-like symptoms and intestinal mucosal injury after cancer chemotherapy.

Eiichi Tsuji1, Naoki Hiki, Sachiyo Nomura, Ryoji Fukushima, Jun-ichi Kojima, Toshihisa Ogawa, Ken-ichi Mafune, Yoshikazu Mimura, Michio Kaminishi.   

Abstract

Chemotherapy is 1 method for the treatment of cancer, but serious side effects can sometimes limit the dosage given. Mild fever and diarrhea are common side effects of cancer chemotherapy. Gastrointestinal injury induced by chemotherapeutic agents may result in bacterial/endotoxin translocation from the gut into the systemic circulation. An experimental study was therefore conducted to clarify the effect of systemic chemotherapeutic agents on gastrointestinal barrier function. Male Wistar rats were divided into a 5-fluorouracil (5-FU) group (100 mg/kg/day for 4 days; n = 27) and a control group (n = 5). All rats were fasted and central venous catheterization was performed for total parenteral nutrition and blood sampling. Intestinal tissue was also sampled for pathological examination. Plasma levels of interleukin-6 (IL-6) and tumor necrosis factor alpha (TNFalpha) were determined by ELISA, bacterial translocation was quantified by lymph node culture and plasma endotoxin content of portal blood was measured by the Limulus-amebocyte-lysate test. In the 5-FU group on day 4, a proportion of rats exhibited severe watery diarrhea (73.9%) and occasional vomiting (86.2%). The levels of plasma TNFalpha and IL-6 were seen to increase, peaking at day 6 (IL-6, 350.0 +/- 67.8 pg/ml; TNFalpha, 26.1 +/- 3.2 pg/ml). The pathological findings also changed on day 4. On day 6, 90% of the rats in the 5-FU group showed dramatic sepsis-like manifestations, whereas the control group did not. Within the 5-FU group, only at day 6 was bacterial translocation in the rat mesenteric lymph nodes or significantly elevated levels of endotoxin evident. These results suggest that bacterial/endotoxin translocation might cause sepsis-like manifestations after systemic chemotherapy. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12949812     DOI: 10.1002/ijc.11196

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

1.  The role of IL-1β and TNF-α signaling in the genesis of cancer treatment related symptoms (CTRS): a study using cytokine receptor-deficient mice.

Authors:  Logan B Smith; Michael C Leo; Caroline Anderson; Teresa J Wright; Kristianna B Weymann; Lisa J Wood
Journal:  Brain Behav Immun       Date:  2014-01-08       Impact factor: 7.217

2.  Isolation and concentration of bacteria from blood using microfluidic membraneless dialysis and dielectrophoresis.

Authors:  L D'Amico; N J Ajami; J A Adachi; P R C Gascoyne; J F Petrosino
Journal:  Lab Chip       Date:  2017-03-29       Impact factor: 6.799

3.  RBM4 modulates the proliferation and expression of inflammatory factors via the alternative splicing of regulatory factors in HeLa cells.

Authors:  Wei-Yang Wang; Weili Quan; Fan Yang; Ya-Xun Wei; Jia-Jun Chen; Han Yu; Jie Xie; Yi Zhang; Zhan-Fei Li
Journal:  Mol Genet Genomics       Date:  2019-09-05       Impact factor: 3.291

4.  Detection of bacteria in blood circulation in patients receiving cancer chemotherapy.

Authors:  Akiko Ota; Sachi Morita; Ayumu Matsuoka; Tomoya Shimokata; Osamu Maeda; Ayako Mitsuma; Tetsuya Yagi; Takashi Asahara; Yuichi Ando
Journal:  Int J Clin Oncol       Date:  2019-08-12       Impact factor: 3.402

5.  Gastrointestinal toxicities of 5-fluorouracil increase the proportion of regulatory T cells in intestinal tract: advantages of alternate-day S-1 administration.

Authors:  Taiki Kajiwara; Koh Miura; Shinobu Ohnuma; Miki Shimada; Toshihiro Komura; Masahide Toshima; Atsushi Kohyama; Katsuyoshi Kudoh; Sho Haneda; Hiroaki Musha; Takeshi Naitoh; Tetsuhiko Shirasaka; Michiaki Unno
Journal:  Int J Clin Oncol       Date:  2015-02-05       Impact factor: 3.402

6.  Effects of caloric intake on intestinal mucosal morphology and immune cells in rats treated with 5-Fluorouracil.

Authors:  Mariko Murakami; Norifumi Sato; Katsufumi Tashiro; Tsuyoshi Nakamura; Hiroaki Masunaga
Journal:  J Clin Biochem Nutr       Date:  2009-06-30       Impact factor: 3.114

Review 7.  Inflammation and neural signaling: etiologic mechanisms of the cancer treatment-related symptom cluster.

Authors:  Lisa J Wood; Kristianna Weymann
Journal:  Curr Opin Support Palliat Care       Date:  2013-03       Impact factor: 2.302

8.  Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies.

Authors:  Dominique M Vandijck; Dominique D Benoit; Pieter O Depuydt; Fritz C Offner; Stijn I Blot; Anna K Van Tilborgh; Joke Nollet; Eva Steel; Lucien A Noens; Johan M Decruyenaere
Journal:  Intensive Care Med       Date:  2008-01-24       Impact factor: 17.440

9.  Protein fraction of Calotropis procera latex protects against 5-fluorouracil-induced oral mucositis associated with downregulation of pivotal pro-inflammatory mediators.

Authors:  Ana Paula F Freitas; Flavio S Bitencourt; Gerly Anne C Brito; Nylane Maria N de Alencar; Ronaldo A Ribeiro; Roberto Cesar P Lima-Júnior; Marcio V Ramos; Mariana L Vale
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-07-14       Impact factor: 3.000

Review 10.  Sources and Functions of Extracellular Small RNAs in Human Circulation.

Authors:  Joëlle V Fritz; Anna Heintz-Buschart; Anubrata Ghosal; Linda Wampach; Alton Etheridge; David Galas; Paul Wilmes
Journal:  Annu Rev Nutr       Date:  2016-05-13       Impact factor: 11.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.